Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer

Z Jiang, M Zhu, L Zhang, H Cui, R Jiang, Y Yang - Gynecologic Oncology, 2024 - Elsevier
Abstract Objective: FAT3 and LRP1B are two tumor suppressor genes with high mutation
frequency in multiple cancer types, we sought to investigate the prognostic and …
被引用次数：1 相关文章

Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer

Z Jiang, M Zhu, L Zhang, H Cui… - Gynecologic …, 2024 - gynecologiconcology-online.net
Abstract Objective: FAT3 and LRP1B are two tumor suppressor genes with high mutation
frequency in multiple cancer types, we sought to investigate the prognostic and …

Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer.

Z Jiang, M Zhu, L Zhang, H Cui, R Jiang… - Gynecologic …, 2024 - europepmc.org
Objective FAT3 and LRP1B are two tumor suppressor genes with high mutation frequency in
multiple cancer types, we sought to investigate the prognostic and immunological …

Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer

Z Jiang, M Zhu, L Zhang, H Cui, R Jiang… - Gynecologic … - pubmed.ncbi.nlm.nih.gov
Objective FAT3 and LRP1B are two tumor suppressor genes with high mutation frequency in
multiple cancer types, we sought to investigate the prognostic and immunological …

Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer

Z Jiang, M Zhu, L Zhang, H Cui… - Gynecologic …, 2024 - gynecologiconcology-online.net
Abstract Objective: FAT3 and LRP1B are two tumor suppressor genes with high mutation
frequency in multiple cancer types, we sought to investigate the prognostic and …